Results 91 to 100 of about 33,029 (292)

Overview of Anemia Among Systemic Lupus Erythematosus Patients in Reproductive Age Women Based on Reticulocyte Hemoglobin Equivalent (RET-He) Level and Reticulocyte Count [PDF]

open access: yes, 2017
Background: Anemia is a common manifestation found among patients with Systemic Lupus Erythematosus (SLE). It may be caused by iron-deficiency, autoimmune hemolytic, and chronic inflammation. Each anemia has different therapy approachments.
Ghozali, M. (Mohammad)   +3 more
core  

Vitiligo and autoimmune thyroid disorders [PDF]

open access: yes, 2017
Vitiligo represents the most common cause of acquired skin, hair and oral depigmentation, affecting 0.5-1% of the population worldwide. It is clinically characterized by the appearance of disfiguring circumscribed skin macules following melanocyte ...
Baldini, Enke   +10 more
core   +2 more sources

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth   +5 more
wiley   +1 more source

A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug‐induced immune haemolytic anaemia

open access: yes
British Journal of Haematology, EarlyView.
Guillaume Brenac   +7 more
wiley   +1 more source

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

open access: yesVeterinary Dermatology, EarlyView.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis   +9 more
wiley   +1 more source

Tuberculosis-induced Autoimmune Hemolytic Anemia

open access: yesJournal of the Indian Academy of Geriatrics
Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by antibodies against one’s own red blood cells, often difficult to diagnose and treat in the elderly. It can be secondary to an infection, drug, or a myeloproliferative disorder.
Shreya Biswal, Prasun Chatterjee
doaj   +1 more source

Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients. [PDF]

open access: yes, 2019
OBJECTIVES: Eosinophilic fasciitis (EF) was described in 1974 by Shulman as a rare fibrosing connective tissue disease of unknown etiology. An undetermined trigger is thought to lead to the degranulation of eosinophils that interact with fibroblasts and
Cimbron, M   +3 more
core   +1 more source

Real‐world efficacy and safety of immunochemotherapy in cold agglutinin‐mediated autoimmune haemolytic anaemia

open access: yes
British Journal of Haematology, EarlyView.
Femke V. M. Mulder   +20 more
wiley   +1 more source

Manufacturing stresses do not differentially impact red blood cells from donors with diabetes

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives With the rising prevalence of diabetes and expanded blood donor criteria in Canada, individuals with diabetes are increasingly contributing to the blood supply. However, little is known about how routine manufacturing affects red blood cells (RBCs) from this group.
Celina Phan   +7 more
wiley   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients

open access: yesAmerican Journal of Hematology, Volume 100, Issue 11, Page 1972-1982, November 2025.
ABSTRACT Only few data are available regarding the efficacy and safety of thrombopoietin receptor agonists (TPO‐RAs) for treating systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS)‐associated immune thrombocytopenia (ITP). We retrospectively assessed the efficacy and safety of TPO‐RAs in 80 adults with ITP in three subgroups: (1)
Cindy Marques   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy